APA

Aapro M. S., van Wijk F. H., van der Burg M. E. L., ten Bokkel Huinink W., Vergote I., Guastalla J. P., Rosso R., Kobierska A., Beex L. V. A., Namer M., Splinter T. E. W. & Vermorken J. B. (20030701). Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group. : European journal of cancer (Oxford, England : 1990).

Chicago

Aapro M S, van Wijk F H, van der Burg M E L, ten Bokkel Huinink W, Vergote I, Guastalla J P, Rosso R, Kobierska A, Beex L V A, Namer M, Splinter T E W and Vermorken J B. 20030701. Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group. : European journal of cancer (Oxford, England : 1990).

Harvard

Aapro M. S., van Wijk F. H., van der Burg M. E. L., ten Bokkel Huinink W., Vergote I., Guastalla J. P., Rosso R., Kobierska A., Beex L. V. A., Namer M., Splinter T. E. W. and Vermorken J. B. (20030701). Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group. : European journal of cancer (Oxford, England : 1990).

MLA

Aapro M S, van Wijk F H, van der Burg M E L, ten Bokkel Huinink W, Vergote I, Guastalla J P, Rosso R, Kobierska A, Beex L V A, Namer M, Splinter T E W and Vermorken J B. Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group. : European journal of cancer (Oxford, England : 1990). 20030701.